NIH/NIDDK DRC
Diabetes Research Center
Featured News & Media
The U.S. Food and Drug Administration has approved Tzield (teplizumab) injection to delay the loss of the body’s own insulin production for...
In recognition of her extraordinary scientific career and transformative contributions to immunology, Professor at Diabetes Center, Department of Surgery, Gladstone-UCSF Institute of Genomic...
UCSF Diabetes Center director Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of Medicine at UC San Francisco, has been elected to the National Academy of Sciences — one of the...
Nearly 40 years ago, UCSF scientists ushered in the era of type 1 diabetes prevention. UCSF Diabetes Center is now working to solve the biggest challenges standing between patients and functional...